Get startedLog in
    Picture of Basilea Pharmaceutica AG, Allschwil logo

    BSLN — Basilea Pharmaceutica AG, Allschwil News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Basilea Announces Sale Of Preclinical Oncology Program To Nodus Oncology

    Picture of Basilea Pharmaceutica AG, Allschwil logoBasilea Pharmaceutica AG, Allschwil
    08/09/2022 06:21
    Sept 8 (Reuters) - Basilea Pharmaceutica AG  BSLN.S :
    * BASILEA ANNOUNCES SALE OF PRECLINICAL ONCOLOGY PROGRAM TO
NODUS
ONCOLOGY

Further company coverage:  BSLN.S 

 (Reporting by Berlin Newsroom)
 ((berlin.newsroom@thomsonreuters.com;))

    Recent news on Basilea Pharmaceutica AG, Allschwil

    See all news